SGS Introduces the Cobas 6000 Analyzer Series - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SGS Introduces the Cobas 6000 Analyzer Series


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 7

SGS Life Science Services has acquired a Cobas 6000 Analyzer System, chemistry module, for use at its Poitiers, France laboratory. This platform allows the determination of a large number of biological parameters (biomarkers) and metabolites, in as little as two minutes, with precision and reliability, using very small sample volumes.

Employing the concept of "open" technology, the Cobas 6000 provides for easy-to-use reagents as well as those not provided by the manufacturer. This promotes the optimization of protocols and allows SGS to offer additional tests that can be validated based upon the company’s expertise. In order to meet the requirements of bioanalytical Good Laboratory Practice (GLP), all results are entered directly into the Watson Laboratory Information Management System for traceability of analysis and can be grouped by patient, even if the results are obtained during long-term kinetics.

Source: SGS Life Science Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here